Anagenics Limited (AU:AN1) has released an update.
Anagenics Limited, a beauty and wellness firm, is undergoing a business simplification program to address profitability challenges by reducing overhead and streamlining its structure, following the divestiture of Face MediGroup. The company has voluntarily suspended trading of its securities to finalize restructuring efforts aimed at ensuring financial sustainability, with updates expected by the end of October 2024. CEO Karen Mathews is set to retire, with existing management of subsidiary BLC Cosmetics to report directly to Anagenics’ Board.
For further insights into AU:AN1 stock, check out TipRanks’ Stock Analysis page.